{
  "ptid_time": "007_S_0128_2006-01-16",
  "img_path": "/data/qiuhui/data/adni/images/007_S_0128/2006-01-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 22,868 mm³, 2.4% above the reference mean. With a Z-score of 0.06 (52.4th percentile), this represents normal volume ; hippocampal volume measures 6,262 mm³, 18.5% below the reference mean. With a Z-score of -2.08 (1.9th percentile), this represents significant atrophy; whole brain volume measures 853,546 mm³, 17.1% below the reference mean. With a Z-score of -2.12 (1.7th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,777 mm³, 28.7% below the reference mean. With a Z-score of -2.22 (1.3th percentile), this represents significant atrophy; fusiform gyrus volume measures 15,900 mm³, 12.7% below the reference mean. With a Z-score of -1.43 (7.7th percentile), this represents mild atrophy; middle temporal gyrus volume measures 16,497 mm³, 19.6% below the reference mean. With a Z-score of -1.74 (4.1th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 64.1 years. Gender is Female. Education: 20 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Major Surgical Procedures. MMSE: 29.0. Logical Memory: 1.0. APOEε4 alleles: 2.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus, whole brain, entorhinal cortex, and middle temporal gyrus, which are key regions affected in Alzheimer's disease (AD). Despite the high MMSE score (29/30), the structural changes, particularly the hippocampal atrophy (Z-score -2.08, 1.9th percentile), strongly suggest neurodegeneration. The presence of two APOE4 alleles further increases AD risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology)  \n**Confidence:** **High** (due to clear structural atrophy in AD-vulnerable regions, despite preserved MMSE)  \n\n*Note: The discrepancy between imaging and MMSE suggests early-stage MCI, where cognitive performance may still be near-normal despite underlying neurodegeneration. Follow-up cognitive testing (e.g., MoCA, neuropsychological battery) and biomarker confirmation (e.g., CSF Aβ/tau or PET) would strengthen the diagnosis.*",
  "timestamp": "2025-07-25T21:46:22.770404"
}